2WQB

Structure of the Tie2 kinase domain in complex with a thiazolopyrimidine inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free: 0.259 
  • R-Value Work: 0.196 
  • R-Value Observed: 0.199 

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Novel Thienopyrimidine and Thiazolopyrimidine Kinase Inhibitors with Activity Against Tie-2 in Vitro and in Vivo.

Luke, R.W.Ballard, P.Buttar, D.Campbell, L.Curwen, J.Emery, S.C.Griffen, A.M.Hassall, L.Hayter, B.R.Jones, C.D.Mccoull, W.Mellor, M.Swain, M.L.Tucker, J.A.

(2009) Bioorg Med Chem Lett 19: 6670

  • DOI: 10.1016/j.bmcl.2009.10.001
  • Primary Citation of Related Structures:  
    2WQB

  • PubMed Abstract: 
  • The SAR and improvement in potency against Tie2 of novel thienopyrimidine and thiazolopyrimidine kinase inhibitors are reported. The crystal structure of one of these compounds bound to the Tie-2 kinase domain is consistent with the SAR. These compounds have moderate potency in cellular assays of Tie-2 inhibition, good physical properties, DMPK, and show evidence of in vivo inhibition of Tie-2 ...

    The SAR and improvement in potency against Tie2 of novel thienopyrimidine and thiazolopyrimidine kinase inhibitors are reported. The crystal structure of one of these compounds bound to the Tie-2 kinase domain is consistent with the SAR. These compounds have moderate potency in cellular assays of Tie-2 inhibition, good physical properties, DMPK, and show evidence of in vivo inhibition of Tie-2.


    Organizational Affiliation

    Cancer and Infection Research Area, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, UK. richard.luke@astrazeneca.com



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
ANGIOPOIETIN-1 RECEPTOR A324Homo sapiensMutation(s): 1 
Gene Names: TEKTIE2VMCMVMCM1
EC: 2.7.10.1
Find proteins for Q02763 (Homo sapiens)
Explore Q02763 
Go to UniProtKB:  Q02763
NIH Common Fund Data Resources
PHAROS:  Q02763
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
QQ1
Query on QQ1

Download Ideal Coordinates CCD File 
A
2-[3-(CYCLOHEXYLMETHYL)-5-PHENYL-IMIDAZOL-4-YL]-[1,3]THIAZOLO[4,5-E]PYRIMIDIN-7-AMINE
C21 H22 N6 S
FACMGTJQTMTYEF-UHFFFAOYSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
QQ1IC50:  540   nM  BindingDB
QQ1IC50 :  540   nM  PDBBind
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.95 Å
  • R-Value Free: 0.259 
  • R-Value Work: 0.196 
  • R-Value Observed: 0.199 
  • Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 80.164α = 90
b = 108.791β = 90
c = 101.573γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MOSFLMdata reduction
SCALAdata scaling
AMoREphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2009-11-03
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Advisory, Refinement description, Version format compliance
  • Version 1.2: 2013-04-17
    Changes: Derived calculations, Refinement description
  • Version 1.3: 2019-03-06
    Changes: Data collection, Experimental preparation, Other